EUVIMEDEUVIMED entdecken
Crossref

Acrodermatitis‐like rash induced by infliximab in an immunoglobulin‐resistant case of Kawasaki disease

Yusuke Morita, Daisuke Matsubara iD, Mitsuru Seki iD, Takaomi Minami, Atsuko Sato, Mayumi Komine, Toshihiro Tajima

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 30.04.2025. Verfasst von Yusuke Morita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Jichi Medical University, Shimotsuke, Tochigi, Japan. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

acrodermatitis‐like rashimmunoglobulin‐resistant Kawasaki diseaseinfantile eczemainfliximab

Autor:innen und Institutionen

  • Department of Pediatrics, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Department of Dermatology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

ORCID-Profile: Daisuke Matsubara, Mitsuru Seki

Zitieren

APA

Morita, Y., Matsubara, D., Seki, M., Minami, T., Sato, A., Komine, M., & Tajima, T. (2025). Acrodermatitis‐like rash induced by infliximab in an immunoglobulin‐resistant case of Kawasaki disease. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70062

Vancouver

Morita Y, Matsubara D, Seki M, Minami T, Sato A, Komine M, et al. Acrodermatitis‐like rash induced by infliximab in an immunoglobulin‐resistant case of Kawasaki disease. Pediatrics International. 2025;67(1). doi:10.1111/ped.70062

BibTeX
@article{Morita2025,
  author = {Morita, Yusuke and Matsubara, Daisuke and Seki, Mitsuru and Minami, Takaomi and Sato, Atsuko and Komine, Mayumi and Tajima, Toshihiro},
  title = {Acrodermatitis‐like rash induced by infliximab in an immunoglobulin‐resistant case of Kawasaki disease},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70062}
}
Kostenlos starten →